Official data from INPI

122021026500

Em AnáliseUtility ModelPCT · US2017053333

Talk to an expert

Application data

Number

122021026500

Type

Utility Model

Filing

09/25/2017

Publication

PCT

US2017053333

View on INPI

Progress at the INPI

Under appeal

Filing09/25/17
Publication
Examination
Allowance
Grant
In force

The application is under appeal: the INPI has yet to review the decision.

Latest action published by the INPI: 10/21/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

EIRION THERAPEUTICS, INC.

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Petição de recurso

#12.2

Recurso: Petição 870250093534, de 13/10/2025

10/21/2025

RPI 2859

Indeferimento

#9.2

08/12/2025

RPI 2849

Conhecimento de parecer técnico

#7.1

04/08/2025

RPI 2831

Notificação de pedido dividido

#2.4

01/11/2022

RPI 2662

Requerimento de pedido de patente

#2.10

Número de Protocolo '870210120831' em 27/12/2021 15:33 (WB)

01/04/2022

RPI 2661

From the same holder

112026006058 122026020830 USOS DE UM AGENTE GRANDE TENDO UM PESO MOLECULAR IGUAL OU SUPERIOR A 100.000 NO RETARDO DE EFEITO DE PICO E/OU PROLONGAMENTO DE DURAÇÃO DE RESPOSTA USO DE AGENTES GRANDES, EMPLASTRO E KIT USO DE AGENTES GRANDES, EMPLASTRO E KIT 122023017558 122023017087 USOS DE INIBIDORES DE INIBIDOR DE ATIVADOR DE PLASMINOGÊNIO 1 (PAI-1)

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.